Qiagen N.V. (BIT:1QGEN)

Italy flag Italy · Delayed Price · Currency is EUR
40.91
0.00 (0.00%)
Last updated: Jul 16, 2025
Market Cap9.13B
Revenue (ttm)1.85B
Net Income (ttm)86.67M
Shares Outn/a
EPS (ttm)0.39
PE Ratio105.40
Forward PE20.59
Dividend1.45 (3.54%)
Ex-Dividend DateJul 2, 2025
Volumen/a
Average Volume76
Open40.91
Previous Close40.91
Day's Range40.91 - 40.91
52-Week Range35.36 - 46.40
Betan/a
RSI96.48
Earnings DateJul 28, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and... [Read more]

Sector Healthcare
Founded 1984
Employees 5,396
Stock Exchange Borsa Italiana
Ticker Symbol 1QGEN
Full Company Profile

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD Financial Statements

News

There is no news available yet.